[1]
“New treatment for non-Hodgkin B-cell lymphomas with a special focus on the impact of junctional adhesion molecules”, Swiss Med Wkly, vol. 147, no. 3738, p. w14487, Sep. 2017, doi: 10.4414/smw.2017.14487.